Related Experiment Video
Updated: Aug 12, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Glucose-Insulin-Potassium Does Not Reduce Myocardial Infarct Size in an Ischemic/Reperfusion Rabbit Model
Journal of Thrombosis and Thrombolysis
|December 23, 1999
Summary
Glucose-insulin-potassium (GIK) therapy did not reduce myocardial infarct size in a rabbit model of ischemia-reperfusion. Despite increased glucose levels, GIK infusion showed no cardioprotective effect on infarct size.
Area of Science:
- Cardiovascular research
- Ischemia-reperfusion injury
- Myocardial infarction
Background:
- Glucose-insulin-potassium (GIK) is proposed to offer cardioprotection.
- Limited data exists on GIK's impact on infarct size in ischemia-reperfusion.
Purpose of the Study:
- To evaluate the effect of GIK on anatomic myocardial infarct size.
- To assess GIK's cardioprotective potential in an ischemia-reperfusion rabbit model.
Main Methods:
- Rabbits underwent 30-minute coronary artery occlusion followed by 4 hours of reperfusion.
- Pretreatment involved a 90-minute GIK infusion or placebo.
- Myocardial infarct size was quantified relative to the area at risk.
Main Results:
- GIK infusion significantly increased serum glucose levels (over twofold).
- GIK did not reduce the area of necrosis relative to the area at risk (25% for GIK vs. 20% for control).
Conclusions:
- GIK therapy failed to reduce myocardial infarct size in this rabbit model.
- The cardioprotective hypothesis of GIK in ischemia-reperfusion warrants further investigation.
